A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer

✍ Scribed by Takeshi Kato; Hideyuki Mishima; Masakazu Ikenaga; Kouhei Murata; Hideyuki Ishida; Mutsumi Fukunaga; Hirofumi Ota; Shusei Tominaga; Tadashi Ohnishi; Masahiro Amano; Kimimasa Ikeda; Masataka Ikeda; Mitsugu Sekimoto; Junichi Sakamoto; Morito Monden

• Publisher: Springer
• Year: 2007
• Tongue: English
• Weight: 259 KB
• Volume: 61
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-007-0471-2